Cargando…
The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations
Fear of hypoglycemia is a common barrier to exercise and physical activity for individuals with type 1 diabetes. While some of the earliest studies in this area involved only one or two participants, the link between exercise, exogenous insulin, and hypoglycemia was already clear, with the only sugg...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902845/ https://www.ncbi.nlm.nih.gov/pubmed/31827338 http://dx.doi.org/10.2147/OAJSM.S149257 |
_version_ | 1783477744702586880 |
---|---|
author | Yardley, Jane E |
author_facet | Yardley, Jane E |
author_sort | Yardley, Jane E |
collection | PubMed |
description | Fear of hypoglycemia is a common barrier to exercise and physical activity for individuals with type 1 diabetes. While some of the earliest studies in this area involved only one or two participants, the link between exercise, exogenous insulin, and hypoglycemia was already clear, with the only suggested management strategies being to decrease insulin dosage and/or consume carbohydrates before and after exercise. Over the past 50 years, a great deal of knowledge has been developed around the impact of different types and intensities of exercise on blood glucose levels in this population. Recent decades have also seen the development of technologies such as continuous glucose monitors, faster-acting insulins and commercially available insulin pumps to allow for the real-time observation of interstitial glucose levels, and more precise adjustments to insulin dosage before, during and after activity. As such, there are now evidence-based exercise and physical activity guidelines for individuals with type 1 diabetes. While the risk of hypoglycemia has not been completely eliminated, therapy recommendations have evolved considerably. This review discusses the evolution of the knowledge and the technology related to type 1 diabetes and exercise that have allowed this evolution to take place. |
format | Online Article Text |
id | pubmed-6902845 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-69028452019-12-11 The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations Yardley, Jane E Open Access J Sports Med Review Fear of hypoglycemia is a common barrier to exercise and physical activity for individuals with type 1 diabetes. While some of the earliest studies in this area involved only one or two participants, the link between exercise, exogenous insulin, and hypoglycemia was already clear, with the only suggested management strategies being to decrease insulin dosage and/or consume carbohydrates before and after exercise. Over the past 50 years, a great deal of knowledge has been developed around the impact of different types and intensities of exercise on blood glucose levels in this population. Recent decades have also seen the development of technologies such as continuous glucose monitors, faster-acting insulins and commercially available insulin pumps to allow for the real-time observation of interstitial glucose levels, and more precise adjustments to insulin dosage before, during and after activity. As such, there are now evidence-based exercise and physical activity guidelines for individuals with type 1 diabetes. While the risk of hypoglycemia has not been completely eliminated, therapy recommendations have evolved considerably. This review discusses the evolution of the knowledge and the technology related to type 1 diabetes and exercise that have allowed this evolution to take place. Dove 2019-12-06 /pmc/articles/PMC6902845/ /pubmed/31827338 http://dx.doi.org/10.2147/OAJSM.S149257 Text en © 2019 Yardley. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Yardley, Jane E The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations |
title | The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations |
title_full | The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations |
title_fullStr | The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations |
title_full_unstemmed | The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations |
title_short | The Athlete with Type 1 Diabetes: Transition from Case Reports to General Therapy Recommendations |
title_sort | athlete with type 1 diabetes: transition from case reports to general therapy recommendations |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902845/ https://www.ncbi.nlm.nih.gov/pubmed/31827338 http://dx.doi.org/10.2147/OAJSM.S149257 |
work_keys_str_mv | AT yardleyjanee theathletewithtype1diabetestransitionfromcasereportstogeneraltherapyrecommendations AT yardleyjanee athletewithtype1diabetestransitionfromcasereportstogeneraltherapyrecommendations |